Source:http://linkedlifedata.com/resource/pubmed/id/19330909
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2009-3-27
|
pubmed:abstractText |
A cocktail of 4 monoclonal anti-type II collagen antibodies recognizing conserved epitopes located within the CB11 fragment (CII 124-402) of type II collagen is currently used as an arthritogenic antibody preparation for inducing collagen antibody induced arthritis (CAIA). In order to increase the arthritogenicity of this cocktail, we have developed 7 new monoclonal antibodies to anti-type II collagen from spleen cells of DBA/1J mice immunized with bovine type II collagen, and tested for their additional effect on the arthritogenicity over that of the current 4-clone cocktail. Three of the clones (CII-3, -5 and -6) bind to the LyC1 (CII 124-290) peptide of CB11 and 1 (CII-7) of the clones binds to CB9.7 (CII 898-1020), and highly cross-reacted with other species of type II collagen. This indicates that these clones recognize conserved epitopes within type II collagen, including mouse type II collagen. On the other hand, 2 other clones (CII-1 and -4) directed against CB9.7 and 1 clone (CII-2) against CB8 (CII 403-551) were less reactive with other species of type II collagen. The arthritogenicity of the current 4-clone cocktail was significantly increased by addition of a fifth clone, CII-3. No effects were observed with other clones. The arthritogenicity of this new 5-clone cocktail was 2-fold greater than the current 4-clone cocktail in all strains of mice tested: the CIA-responder strain DBA/1J, the CIA-resistant BALB/c (H-2(d)), the T-cell deficient C.B-17/l scid/scid and the CAIA-low responder C57BL/6 (H-2(b)) strain. These results clearly indicated the importance of epitope specificity of arthritogenicity of autoantibodies to type II collagen. Due to its enhanced arthritogenicity, this 5-clone cocktail is capable of inducing a more consistent and severe arthritis with lower doses compared to the current 4-clone cocktail, and will provide an effective new reagent for inducing arthritis in various strains of CAIA low responder mice.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1872-7905
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
31
|
pubmed:volume |
343
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
49-55
|
pubmed:dateRevised |
2009-4-6
|
pubmed:meshHeading |
pubmed-meshheading:19330909-Animals,
pubmed-meshheading:19330909-Antibodies, Anti-Idiotypic,
pubmed-meshheading:19330909-Antibodies, Monoclonal,
pubmed-meshheading:19330909-Arthritis, Experimental,
pubmed-meshheading:19330909-Cattle,
pubmed-meshheading:19330909-Collagen Type II,
pubmed-meshheading:19330909-Disease Models, Animal,
pubmed-meshheading:19330909-Epitopes,
pubmed-meshheading:19330909-Hybridomas,
pubmed-meshheading:19330909-Male,
pubmed-meshheading:19330909-Mice,
pubmed-meshheading:19330909-Mice, Inbred BALB C,
pubmed-meshheading:19330909-Mice, Inbred C57BL,
pubmed-meshheading:19330909-Mice, Inbred DBA,
pubmed-meshheading:19330909-Species Specificity
|
pubmed:year |
2009
|
pubmed:articleTitle |
Collagen antibody-induced arthritis in mice: development of a new arthritogenic 5-clone cocktail of monoclonal anti-type II collagen antibodies.
|
pubmed:affiliation |
Department of Pharmacology, Kobe Pharmaceutical University, Kobe-shi, Hyogo-ken, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|